484 related articles for article (PubMed ID: 9686590)
1. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
2. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA
Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742
[TBL] [Abstract][Full Text] [Related]
4. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
[TBL] [Abstract][Full Text] [Related]
5. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat.
Lowry RP; Forbes RD; Blackburn JH; Marghesco DM
Transplantation; 1985 Nov; 40(5):545-50. PubMed ID: 3904091
[TBL] [Abstract][Full Text] [Related]
6. Chronic cardiac allograft rejection in a rat model disparate for one single class I MHC molecule is associated with indirect recognition by CD4(+) T cells.
Shirwan H; Mhoyan A; Yolcu ES; Que X; Ibrahim S
Transpl Immunol; 2003; 11(2):179-85. PubMed ID: 12799202
[TBL] [Abstract][Full Text] [Related]
7. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells internalise and re-present conformationally intact soluble MHC class I alloantigen for generation of alloantibody.
Curry AJ; Pettigrew GJ; Negus MC; Easterfield AJ; Young JL; Bolton EM; Bradley JA
Eur J Immunol; 2007 Mar; 37(3):696-705. PubMed ID: 17266175
[TBL] [Abstract][Full Text] [Related]
9. Allograft rejection in athymic nude rats by transferred T cell subsets. II. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to an isolated MHC class I disparity.
Bell EB; Rejali D; Whitby EH; Sparshott SM; Yang CP
Transplantation; 1990 Oct; 50(4):690-6. PubMed ID: 1977220
[TBL] [Abstract][Full Text] [Related]
10. Alloantibody-associated chronic rejection of MHC class I-disparate heart grafts is modulated by intravenous soluble donor alloantigen.
Easterfield AJ; Delriviere L; Wallduck MS; Sivaganesh S; Bradley JA; Bolton EM
Transpl Immunol; 2007 Nov; 18(2):138-41. PubMed ID: 18005858
[TBL] [Abstract][Full Text] [Related]
11. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of the indirect T cell response to allogeneic class I MHC: sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production.
Lovegrove E; Pettigrew GJ; Bolton EM; Bradley JA
J Immunol; 2001 Oct; 167(8):4338-44. PubMed ID: 11591757
[TBL] [Abstract][Full Text] [Related]
13. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
[TBL] [Abstract][Full Text] [Related]
15. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
[TBL] [Abstract][Full Text] [Related]
16. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
17. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains.
Ilano AL; McConnell MV; Gurley KE; Spinelli A; Pearce NW; Hall BM
J Immunol; 1989 Nov; 143(9):2828-36. PubMed ID: 2572644
[TBL] [Abstract][Full Text] [Related]
18. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
Watschinger B
Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
[TBL] [Abstract][Full Text] [Related]
19. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
[TBL] [Abstract][Full Text] [Related]
20. Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle.
Geissler EK; Wang J; Fechner JH; Burlingham WJ; Knechtle SJ
J Immunol; 1994 Jan; 152(2):413-21. PubMed ID: 8283029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
